AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of AMPHORA® Contraceptive Vaginal Gel

Trial Profile

AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of AMPHORA® Contraceptive Vaginal Gel

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Citric acid/lactic acid/potassium bitartrate (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms AMPOWER
  • Sponsors Evofem Biosciences
  • Most Recent Events

    • 16 Feb 2018 Status changed from recruiting to active, no longer recruiting, according to an Evofem media release.
    • 23 Jan 2018 According to an Evofem media release, this trial is expected to be fully enrolled in late February of 2018 with data reported in the first quarter of 2019.
    • 29 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top